Trial intelligence / Profile preview

Etanercept withdrawal in Juvenile Idiopathic Arthritis

NCT01287715Phase 4Unknown

Sponsor
Erasmus MC
Start
Jan 2011
Primary completion
Sep 2012
Countries
1
01

Overview

A Phase 4 trial of etanercept in juvenile idiopathic arthritis (JIA), sponsored by Erasmus MC. Status: unknown.

02

Drugs

etanercept
03

Conditions

juvenile idiopathic arthritis (JIA)

Beyond the preview

Go deeper on NCT01287715.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01287715.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call